NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/29/2022
Back to search
Official data from USPTO
POLYPHOR INNOVATION IN DRUG DISCOVERY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
10/29/2022
Classification
Registered
Trademark type
Combined
Nice classes
1, 3, 5, 42
Filing date
02/01/2008
Registration date
02/03/2009
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/06/2019
Last transaction
09/06/2019
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
KAUFMAN,LAURIE R
Law office
L30
Current location
TMEG LAW OFFICE 103
Holders and representatives
Holders
Polyphor AG
Representatives
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP
Technical classification
Nice Classes
Class 1Class 3Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; chemical preparations for use in agriculturechemical preparations for the treatment of seeds; and chemical preparations for use in photographychemical developers; unprocessed artificial resins as raw materials in the form of powdersliquids or pastes; unprocessed plastics for industrial use; unprocessed plastics in all forms; fertilizersmanures; fire extinguishing compositions; tempering chemicals for use in metalworking or soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leatheradhesives for general industrial use
Class 3
Bleaching preparations for household use; general purpose cleaningpolishingscouring and abrasive liquids and powders; soaps; perfumeryessential oils for personal use and for use as ingredients in the manufacture of cosmetic preparations; cosmetics; hair lotions; dentifrices
Class 5
Pharmaceutical anti-allergic preparations and substancesPharmaceutical for the treatment of erectile dysfunctionPharmaceutical preparationsanticoagulantsPharmaceutical preparationsantidepressantsPharmaceutical preparationsappetite suppressantsPharmaceutical preparations for use in chemotherapyPharmaceutical preparation for the treatment of goutPharmaceutical preparations for the treatment of heart rhythm disordersPharmaceutical preparations for the treatment of stem cell mobilizationPharmaceutical preparations for the treatment of infectious diseasesPharmaceutical preparations acting on the central nervous systemPharmaceutical preparations and substances for the treatment of gastro-intestinal diseasesPharmaceutical preparations for animal skincarePharmaceutical preparations for inhalation for the treatment of pulmonary hypertensionPharmaceutical preparations for ocular or intraocular surgeryPharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosisPharmaceutical preparations for treating allergic rhinitis and asthmaPharmaceutical preparations for treating diabetesPharmaceutical preparations for treating skin disordersPharmaceutical preparations for use in dermatologyPharmaceutical preparations for woundsPharmaceutical preparations for use in urologyPharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicinePharmaceutical products and preparations against dry skin caused by pregnancyPharmaceutical products and preparations for chloasmaPharmaceutical products and preparations for hydrating the skin during pregnancyPharmaceutical products and preparations for pregnancy blemishesPharmaceutical products and preparations for preventing skin blemishes during pregnancyPharmaceutical products and preparations to prevent stretch marksPharmaceutical products and preparations to prevent swelling in the legsPharmaceutical products for ophthalmological usePharmaceutical products for skin care for animalsPharmaceutical products for the treatment of bone diseasesPharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancerPharmaceutical products for treating respiratory diseases and asthmaPharmaceutical skin lotionsPharmaceutical solutions used in dialysisPharmaceuticalsantihelminticsPharmaceuticalsinducers of erectionsPharmaceuticalslipid lowering agentsPharmaceuticalspsychotropicsPharmaceuticalsanti-infectives; Veterinary preparationspain relief medicationveterinary preparations for the treatment of intestinal bacteriaVeterinary vaccine for horsesVeterinary vaccines; sanitary preparations for medical purposes; dietetic foods adapted for medical usefood for babies; medical plastersdressings for woundsburnssurgery; dental impression materials; disinfectants for hygienic purposes; preparations for destroying vermin; fungicides and herbicides * all of the aforementioned products exclusively as intermediates for research and test purposes and in form of recipes *
Class 42
Scientific and technological services in the nature of research in the field of agrochemicalspharmaceuticals and bio-chemistry and design services relating theretoscientific and technological services relating to properties of agrochemicalspharmaceuticals and bio-chemistry; industrial analysis and research services ; design and development of computer hardware and software
Publications
History of USPTO decisions and trademark events.
46 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2022
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/10/2020
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/11/2020
INPC
INVALIDATION PROCESSED
06/11/2020
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/06/2020
C71T
CANCELLED SECTION 71
09/06/2019
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
12/03/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/22/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/19/2018
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/22/2018
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
02/20/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/15/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/03/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/24/2017
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/20/2015
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/14/2015
INPC
INVALIDATION PROCESSED
10/14/2015
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/29/2015
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/29/2015
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
01/29/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/29/2015
ES71
TEAS SECTION 71 RECEIVED
01/07/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/30/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/18/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/12/2009
FIMP
FINAL DISPOSITION PROCESSED
05/12/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/03/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2009
PUBO
PUBLISHED FOR OPPOSITION
11/18/2008
NPUB
NOTICE OF PUBLICATION
10/29/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/16/2008
ALIE
ASSIGNED TO LIE
10/16/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/25/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/25/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/25/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/25/2008
RFNT
REFUSAL PROCESSED BY IB
06/06/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/16/2008
RFRR
REFUSAL PROCESSED BY MPU
05/16/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/16/2008
CNRT
NON-FINAL ACTION WRITTEN
05/15/2008
DOCK
ASSIGNED TO EXAMINER
05/12/2008
NWAP
NEW APPLICATION ENTERED
04/25/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/24/2008
Continuous trademark protection
Get notified about every new filing that threatens POLYPHOR INNOVATION IN DRUG DISCOVERY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.